Prosecution Insights
Last updated: October 27, 2026

Jalisa Holmes Ferguson, USPTO Patent Examiner

Listed by the USPTO as FERGUSON, JALISA HOLMES

Tech Center 1600 • Art Units: 1626

This examiner grants 62% of resolved cases

Analysis

FERGUSON, JALISA HOLMES has 37 resolved cases in Tech Center 1600 and art unit 1626. The allowance rate is 62.2%, the interview lift is 41.2%, and the median time to allowance is 1205 days. The smaller resolved-case record limits the breadth of inference, but the figures show a notable interview effect within the available data.

The listed companies are Hoffmann-La Roche Inc., Horizon Therapeutics Ireland Dac, and Janssen Pharmaceuticals Inc. The listed firms are BakerHostetler, BIRCH STEWART KOLASCH & BIRCH, LLP, and BROWN RUDNICK LLP. Practitioners may benefit from preparing a defined interview agenda addressing claim scope and the cited art, while maintaining written support for the resulting prosecution position.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

62.2%
Allow Rate
+2.2% vs TC avg
69
Total Applications
+41.2%
Interview Lift
1205
Avg Prosecution Days
Based on 37 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
21.8%
§102 Novelty
17.1%
§103 Obviousness
38.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18844371 PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES Non-Final OA Hoffmann-La Roche Inc.
18833568 LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS Non-Final OA THE UNIVERSITY OF TOKYO
18550326 Methods For Treatment of Vitiligo Non-Final OA Pfizer Inc.
18550306 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN Non-Final OA TAKEDA PHARMACEUTICAL COMPANY LIMITED
18887279 HETEROARYL DERIVATIVE COMPOUNDS, AND USES THEREOF Non-Final OA VORONOI INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jalisa Holmes Ferguson's allowance rate?

62.2% of resolved applications examined by Jalisa Holmes Ferguson were allowed (37 resolved cases), compared with 54.9% across Art Unit 1626 over the last five years.

Does an interview help with examiner Jalisa Holmes Ferguson?

This examiner's interview lift is +41.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jalisa Holmes Ferguson take to allow a patent?

Applications allowed by Jalisa Holmes Ferguson took 1,205 days on average from filing to allowance.

Which art unit does examiner Jalisa Holmes Ferguson work in?

Jalisa Holmes Ferguson examines applications in Art Unit 1626 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month